OXLCL Q4 2025 Earnings EPS Falls Short Amid Mixed Market Signals Tenax Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued Clinical Development GIPR Q1 2026 Earnings NarrowerThanExpected Loss Fails to Avert Stock Decline PENN Q1 2026 Earnings EPS Misses Estimates as Company Reports Adjusted Loss YSS Q1 2026 Earnings EPS Misses Estimates by Wide Margin as PreRevenue Stage Continues Cingulate Inc CING Surges 84 as Bullish Momentum Builds Jones Lang LaSalle JLL Holds Steady Near Support as Volume Remains Subdued Ernexa Therapeutics ERNA Slips 38 as Shares Test Key Support Near 1139 Sachem Capital 8 Notes SCCG Hold Steady Near Par Yield Attraction vs Maturity Risk QBTS Q1 2026 Earnings EPS Beats Estimates by 872 Shares Surge